Literature DB >> 22118631

Assessment of endothelial function in atrial fibrillation: utility of peripheral arterial tonometry.

Christopher X Wong1, Han S Lim, Carlee D Schultz, Prashanthan Sanders, Matthew I Worthley, Scott R Willoughby.   

Abstract

Endothelial function is an independent predictor of adverse cardiovascular outcomes. The evaluation of endothelial function via changes in vessel diameter or blood flow may be inaccurate during atrial fibrillation (AF) because of non-uniform stroke volumes. Using peripheral arterial tonometry, 50 patients with AF (25 in AF, 25 in sinus rhythm) had digital pulse amplitudes assessed at baseline and during reactive hyperaemia. Hyperaemic responses were compared over varying measurement durations (5, 10 and 15beats; 30s; and 1-10min) to determine optimal measurement duration. Endothelial responses were significantly decreased (indicating endothelial dysfunction) in patients in AF compared with patients in sinus rhythm (1.48±0.60 vs 2.05±1.13, respectively; P=0.03). Beat-to-beat pulse amplitude was highly variable during AF; although coefficients of variation (CV) for short measurement durations were large, these decreased with longer measurement durations. Bland-Altman plots revealed that limits of agreement for short measurement durations were poor. Limits of agreement became consistently narrower when measurement durations of at least 1min were used. In contrast, limits of agreement and CV for short measurement durations during sinus rhythm were significantly narrower and smaller, respectively, than during AF over similar measurement durations. Pulse amplitudes are highly variable owing to the non-uniform stroke volumes in AF. Our results suggest that methods of determining endothelial function via vessel diameters or blood flow during reactive hyperaemia should use measurement durations of at least 1min to ensure accurate and reproducible results.
© 2011 The Authors. Clinical and Experimental Pharmacology and Physiology © 2011 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22118631     DOI: 10.1111/j.1440-1681.2011.05647.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  6 in total

1.  Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Elsayed Z Soliman; Faye Lopez; Wesley T O'Neal; Lin Y Chen; Lindsay Bengtson; Zhu-Ming Zhang; Laura Loehr; Mary Cushman; Alvaro Alonso
Journal:  Circulation       Date:  2015-04-27       Impact factor: 29.690

2.  Atrial fibrillation and the risk of myocardial infarction.

Authors:  Elsayed Z Soliman; Monika M Safford; Paul Muntner; Yulia Khodneva; Farah Z Dawood; Neil A Zakai; Evan L Thacker; Suzanne Judd; Virginia J Howard; George Howard; David M Herrington; Mary Cushman
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

3.  Evaluation of the vascular protective effects of new oral anticoagulants in high-risk patients with atrial fibrillation (PREFER-AF): study protocol for a randomized controlled trial.

Authors:  Jin-Bae Kim; Hyun Jun Joung; Jung Myung Lee; Jong Shin Woo; Woo-Shik Kim; Kwon Sam Kim; Kyung Hye Lee; Weon Kim
Journal:  Trials       Date:  2016-08-24       Impact factor: 2.279

4.  Glomerular Filtration Rate as a Predictor of Outcome in Acute Coronary Syndrome Complicated by Atrial Fibrillation.

Authors:  Domenico Santoro; Guido Gembillo; Giuseppe Andò
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

5.  Association between reactive hyperemia peripheral arterial tonometry index and atrial fibrillation recurrence after catheter ablation.

Authors:  Hideki Kobayashi; Ayako Okada; Hiroaki Tabata; Wataru Shoin; Takahiro Okano; Koji Yoshie; Yasutaka Oguchi; Ken Kato; Morio Shoda; Koichiro Kuwahara
Journal:  Int J Cardiol Heart Vasc       Date:  2019-06-20

Review 6.  The imminent epidemic of atrial fibrillation and its concomitant diseases - Myocardial infarction and heart failure - A cause for concern.

Authors:  Christin S Börschel; Renate B Schnabel
Journal:  Int J Cardiol       Date:  2018-11-30       Impact factor: 4.164

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.